Fiduciary Family Office’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$475K Sell
2,148
-2,381
-53% -$582K 0.14% 105
2025
Q4
$1.15M Buy
4,529
+1,777
+65% +$446K 0.33% 54
2025
Q3
$681K Sell
2,752
-2,333
-46% -$558K 0.19% 104
2025
Q2
$1.22M Buy
5,085
+2,241
+79% +$522K 0.4% 54
2025
Q1
$645K Buy
+2,844
New +$626K 0.21% 100
2024
Q4
Sell
-2,996
Closed -$727K 226
2024
Q3
$727K Buy
2,996
+508
+20% +$119K 0.24% 88
2024
Q2
$546K Hold
2,488
0.22% 120
2024
Q1
$559K Sell
2,488
-559
-18% -$126K 0.22% 124
2023
Q4
$670K Buy
+3,047
New +$644K 0.29% 80

Other funds holding STE

Fiduciary Family Office's STE Position: Q1 2026 in Review

Fiduciary Family Office reduced its Steris (STE) stake by 53% in Q1 2026, selling an estimated $582K and leaving 2,148 shares worth $475K. The position accounts for 0.14% of the portfolio, ranked #105.

Fiduciary Family Office first reported a position in STE in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.22M in Q2 2025. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Fiduciary Family Office held 2,148 shares of Steris worth $475K as of Q1 2026.
  • Fiduciary Family Office sold 2,381 Steris shares in Q1 2026, an estimated $582K.
  • Steris made up 0.14% of Fiduciary Family Office's portfolio in Q1 2026, its #105 holding.
  • Fiduciary Family Office first reported a position in Steris in Q4 2023 and has held it in 9 quarters since.
  • Fiduciary Family Office's Steris position peaked at $1.22M in Q2 2025.
  • 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Fiduciary Family Office's 13F filing for Q1 2026, filed 14 May 2026.